Twist Bioscience Corporation TWST Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| DNA synthesis and protein solutions | $116.39M+11.1% | $104.76M+11.7% | $93.78M+1.2% | $92.63M+0.6% | $92.12M+67.0% | |
| NGS applications | $218.4M+3.0% | $212.1M+1.9% | $208.1M+3.7% | $200.61M+6.3% | $188.73M+5.8% | |
| Revenue by Geography | ||||||
| Americas | $239.37M+4.0% | $230.25M+2.1% | $225.58M+2.1% | $220.95M+3.8% | $212.95M+4.6% | |
| APAC | $29.1M+7.8% | $27M+0.9% | $26.75M+2.4% | $26.13M-2.1% | $26.7M-0.8% | |
| EMEA | $141.01M+5.0% | $134.3M+8.1% | $124.24M+7.9% | $115.19M+6.6% | $108.03M+8.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Twist Bioscience Corporation break its business down?
- Twist Bioscience Corporation (TWST) reports revenue by product across 2 parts — DNA synthesis and protein solutions and NGS applications. Each is extracted from the segment footnotes and tracked over time.
- Where does Twist Bioscience Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Twist Bioscience Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.